Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-03-15 Sale |
2021-03-17 4:00 pm |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
13,439 | $15.1 | $202,894 | 269,573 (Direct) |
View |
2021-02-16 Sale |
2021-02-18 8:44 pm |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
20,274 | $15.13 | $306,767 | 150,286 (Direct) |
View |
2021-01-20 Sale(A) |
2021-02-18 8:40 pm |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
2,720 | $15.07 | $40,980 | 19,280 (Direct) |
View |
2021-01-20 Purchase |
2021-01-22 4:33 pm |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
2,720 | $15.07 | $40,980 | 4,720 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-03-25 Option Award |
2022-03-29 4:12 pm |
N/A 2032-03-24 |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
40,000 | $0 | 40,000 (Direct) |
View |
2021-12-20 Option Award |
2021-12-21 4:05 pm |
N/A 2031-12-20 |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
80,000 | $0 | 80,000 (Direct) |
View |
2021-03-15 Exercise |
2021-03-17 4:00 pm |
N/A 2024-04-17 |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
13,439 | $0 | 269,573 (Direct) |
View |
2021-03-15 Exercise |
2021-03-17 4:00 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
13,439 | $5 | 269,573 (Direct) |
View |
2021-02-16 Exercise |
2021-02-18 8:44 pm |
N/A 2023-11-16 |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
20,274 | $0 | 150,286 (Direct) |
View |
2021-02-17 Exercise |
2021-02-18 8:44 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
2,994 | $5 | 150,286 (Direct) |
View |
2021-02-16 Exercise |
2021-02-18 8:44 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
17,280 | $2.86 | 150,286 (Direct) |
View |
2021-01-20 Exercise(A) |
2021-02-18 8:40 pm |
N/A 2023-11-16 |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
2,720 | $0 | 19,280 (Direct) |
View |
2021-01-20 Exercise(A) |
2021-02-18 8:40 pm |
N/A N/A |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
2,720 | $2.86 | 19,280 (Direct) |
View |
2021-02-10 Option Award |
2021-02-12 5:52 pm |
N/A 2031-02-09 |
Cue Biopharma Inc. | CUE | Pienta Kenneth Chief Medical Officer |
50,000 | $0 | 50,000 (Direct) |
View |